Evidence map›Paper›PMID 33976566›Full record

ArticleInternational journal of general medicine2021

Effects of Surgical Intervention for Bone Metastases on Survival in Patients with Advanced Cancer: A Nationwide Population-Based Cohort Study.

Jen-Ta Shih, Tsu-Te Yeh, Pei-Hung Shen, Chih-Chien Wang, Sheng-Hao Wang, Wu-Chien Chien, Chi-Hsiang Chung, Chia-Chun Wu

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jen-Ta ShihDepartment of Orthopedics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Tsu-Te YehDepartment of Orthopedics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Pei-Hung ShenDepartment of Orthopedics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chih-Chien WangDepartment of Orthopedics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Sheng-Hao WangDepartment of Orthopedics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Wu-Chien ChienSchool of Public Health, National Defense Medical Center, Taipei, Taiwan.
Chi-Hsiang ChungSchool of Public Health, National Defense Medical Center, Taipei, Taiwan.
Chia-Chun WuDepartment of Orthopedics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.ORCID 0000-0002-6169-0004
Tri-Service General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWith recent advances in surgical techniques and instruments, orthopedic surgeons are better equipped to treat metastatic bone disease. There has also been considerable progress in the non-surgical treatment of cancers, specifically in improving the survival rate of patients with advanced cancer. However, it remains unclear whether surgical resection of a metastatic bone lesion poses additional risk to the survival of patients with advanced cancer. PATIENTS AND

methodsThis study utilized data from the National Health Insurance Research Database (NHIRD) in Taiwan between 2000 and 2015. Patients aged ≥18 years, who had been recently diagnosed with bone metastases (BM), were enrolled and assigned to either the surgery or non-surgery groups. The demographic characteristics were analyzed, and the adjusted hazard ratios (aHR) of mortality were calculated using Cox regression analysis.

resultsOf the 4,549,226 individuals in the inpatient database of the NHIRD, 83,536 patients with BM were enrolled in this study. Among them, 8802 underwent surgical resection for skeletal metastatic lesion and 66,098 did not. Altogether, 28,691 patients died, including 2798 (31.8%) in the surgery group and 25,893 (39.2%) in the non-surgery group. The aHR for mortality was 0.7-fold lower in the surgery group (p < 0.001).

conclusionThis study demonstrates that surgical resection of metastatic bone lesions did not pose any additional risk to survival outcomes. Thus, we believe that surgery, if indicated, could have a competitive role in the management of metastatic bone disease.

Indexed as

bone metastasisbone resorption inhibitormortalitysurgical resection

Identifiers

PMID33976566
PMCPMC8104989
OpenAlexW3157089549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.